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Background: In patients polysensitized to pollen allergens, the priming effect, by which the 
sensitivity of the nasal mucosa to an allergen is increased by the previous exposure to another 
allergen, is a known phenomenon. This study was aimed at evaluating the degree of nasal 
inflammation, assessed by nasal cytology, in children with allergic rhinitis (AR) from ragweed 
pollen according to being monosensitized or polysensitized.
Methods: The study included 47 children. Of them, 24 suffered from AR caused by sensitization 
to grass pollen and ragweed pollen (group A) and 23 were sensitized only to ragweed pollen 
(group B). In all patients, the severity of AR was assessed according to the Allergic Rhinitis 
and Its Impact on Asthma guidelines, and comorbidities were also evaluated.
Results: In group A, 16.7% of children had a mild intermittent AR, 4.2% a moderate-to-severe 
intermittent, 33.3% a mild persistent, and 45.8% a moderate-to-severe persistent; in group B, 
26.1% of children had a mild intermittent AR, 0% a moderate-to-severe intermittent, 52.2% a mild 
persistent, and 21.7% a moderate-to-severe persistent. No significant difference was detected in the 
number of the considered comorbidities between the two groups. The cell counts of neutrophils, 
eosinophils, lymphocytes/plasma cells, and mast cells were high but not significantly different in 
the two groups.
Conclusion: These findings show that the degree of nasal inflammation found in children with 
ragweed-induced AR is not influenced by additional allergy to grass pollen and confirm the 
previously reported absence of priming effect in ragweed allergy.
Keywords: allergic rhinitis, pollen sensitization, priming effect, nasal cytology, eosinophils, 
neutrophils
Introduction
Ragweed pollen is a major cause of respiratory allergy. In the pioneering age of allergy 
in the 19th century, when Blackley discovered that grass pollen was the cause of hay 
fever, Wyman demonstrated that the so-called autumnal catarrh (hay fever) was due 
to ragweed pollen.1 Ragweed has optimal characteristics to cause allergy because its 
pollen is able to induce respiratory allergy starting from concentrations as low as five 
to ten pollen grains per cubic meter of air and because each plant (as demonstrated for 
Ambrosia artemisiifolia) can produce up to 60,000 seeds, which can germinate even 
after lying up to 40 years in the ground.2 For a long time, ragweed allergy was appar-
ently confined to northern America,3 but in the last few decades, a worldwide diffusion 
of this plant occurred. In Europe, the four species of ragweed, A. artemisiifolia (short 
ragweed), Ambrosia trifida (giant ragweed), Ambrosia coronopifolia (perennial rag-
weed), and Ambrosia tenuifolia (slimleaf bur ragweed), were accidentally introduced 
Journal of Inflammation Research 2016:9submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
22
gelardi et al
to Europe, where previously only Ambrosia maritima was 
known.4 Ragweed allergy was first detected in the Lyon 
region in France,5 followed by northern Italy, Austria, and 
Hungary,6 and more recently, Switzerland.7 In Italy, a spread-
ing of this allergy also to central regions was found, mainly 
caused by long distance transport of pollen.8 These aspects 
make ragweed allergy an individual and social burden in Italy, 
which needs effective treatments. In this study, we aimed to 
evaluate the degree of nasal inflammation, assessed by nasal 
cytology, in children with allergic rhinitis (AR) from ragweed 
pollen according to being monosensitized or polysensitized, 
ie, sensitized also to grass pollen.
Methods
Patients
The population of this study was 47 children. Their demo-
graphic data and kind of sensitization are reported in 
Table 1. Oral informed consent was obtained by both parents 
before entering the study, and the study was conducted in 
accordance with good clinical practice guidelines. Allergic 
sensitization was evaluated by skin prick tests performed by 
allergen extracts from Stallergenes (Antony, France) using 
a complete panel of inhalant allergens, which included for 
grasses  Dactylis glomerata, Phleum pratense, Anthoxanthum 
odoratum, Poa pratensis, and Lolium perenne. To be included 
in the study, the patients must not have any other positive 
tests in addition to those for grass and ragweed pollen. The 
symptomatic periods in the area where patients live are from 
April to June for grass pollen and from late August to early 
October for ragweed pollen. All patients were allowed to 
use antihistamines as needed to treat their symptoms, while 
corticosteroids were not permitted to avoid interference with 
nasal cytology. The severity of AR was assessed according 
to the Allergic Rhinitis and Its Impact on Asthma (ARIA) 
guidelines,9 and comorbidities were also evaluated. The local 
ethical committee, Luigi Sacco Hospital, Milan, Italy, after 
being informed about the procedures to be carried out gave the 
authorization to perform the study. Parents or legal guardians 
gave their written informed consent allowing the inclusion of 
children in the study.
nasal cytology
In all study subjects, nasal cytology was performed by ante-
rior rhinoscopy using a nasal speculum and adequate lighting. 
The cytological sampling consists of collecting the nasal 
mucosa surface cells by scraping from the middle  portion 
of the inferior turbinate using a Rhino-probe™ (Arlington 
Scientific, Springville, UT, USA). When the sampling is 
obtained, the material is placed on a glass slide, fixed by air 
drying, and stained using the May-Grünwald-Giemsa method, 
which allows the detection of all the cellular components of 
the nasal mucosa, including those cells that are associated 
with the immune inflammation process (such as neutrophils, 
eosinophils, lymphocytes/plasma cells, and mast cells). The 
slide is then observed through a light microscope supplied 
with an object-glass, able to magnify up to ×1,000. For the 
rhinocytogram analysis, at least 50 microscopic fields have to 
be read in order to detect all the cells present in the sample.10 
The sampling was performed in all subjects in mid-May 
and mid-September, which are periods corresponding to the 
peak of symptoms from grass pollen and ragweed pollen, 
respectively, in Italy. In the same time periods, the total nasal 
symptom score as reported by Ford et al11 was calculated 
for each patient by the sum of four individual scores, nasal 
congestion, nasal itching, rhinorrhea, and sneezing, in which 
each symptom was scored on a scale of 0–3.
statistical analysis
The comparison between the two groups of patients for the 
variables of the continuous type was performed by means 
of Student’s t-test by calculating the 95% confidence inter-
val. In the case of nonhomogeneity of the variances of the 
two groups, the nonparametric Mann–Whitney U test was 
used. The analysis of discrete or nominal parameters was 
performed using the Fisher’s exact test or the chi-square test. 
A P-value of at least ,0.05 was considered significant.
Results
Twenty-four children were allergic to grass pollen and rag-
weed pollen and formed group A, while 23 were allergic only 
to ragweed pollen and formed group B (Table 1). The distri-
bution of the clinical forms according to ARIA classification 
was as follows: in group A, four (16.7%) children had a mild 
intermittent AR, one (4.2%) a moderate-to-severe intermit-
tent, eight (33.3%) a mild persistent, and eleven (45.8%) 
a moderate-to-severe persistent; in group B, six (26.1%) 
children had a mild intermittent AR, zero (0%) a moderate-
to-severe intermittent, 12 (52.2%) a mild persistent, and 
five (21.7%) a moderate-to-severe persistent. None of these 
differences were statistically significant. Asthma was  present 
Table 1 Demographic data and kind of sensitization in the two 
groups of patients
Patients 
characteristics
Group A Group B
sex (male/female) 9/15 10/13
Mean age (years) 10.2±3.2 9.7±3.5
sensitization grass pollen and  
ragweed pollen
Ragweed pollen
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in 25% of subjects in group A and in 30.4% of subjects in 
group B. The number of the considered comorbidities in the 
two groups is reported in Table 2. No significant difference 
was detected. The mean total nasal symptom score was 
8.5±4.7 in patients allergic only to ragweed and 8.0±5.2 in 
patients allergic to both grass and ragweed pollen. The cell 
counts of neutrophils, eosinophils, lymphocytes/plasma cells, 
and mast cells, as assessed by nasal cytology, were high but 
not significantly different in subjects of group A and group B 
(Figure 1). Figure 2 shows a typical rhinocytogram obtained 
in patients with ragweed pollen allergy.
Discussion
Pollen allergy is a very common form of immunoglobulin 
E (IgE)-mediated hypersensitivity. The process of sensi-
tization takes place when during seasonal exposure the 
antigenic proteins contained in pollen grains come into 
contact with antigen-presenting cells, which present them 
to T and B lymphocytes, with subsequent production of 
specific antibodies. In atopic subjects, the prevalence of 
a Th2 cytokine pattern results in an IgE response.12 Then, 
the Fc portion of IgE antibodies binds to the high-affinity 
receptors on the surface of mast cells, and when subsequent 
exposure to the same allergens occurs, the cross-linking of 
two or more IgE molecules elicits degranulation of mast 
cells with release of mediators and development of clinical 
symptoms. This corresponds to the early phase of the aller-
gic reaction, but the ensuing recruitment of inflammatory 
cells results in a late-phase reaction that sustains the ongo-
ing  symptomatology. A  phenomenon occurring in the initial 
phases of pollen allergy is the priming effect, by which 
the sensitivity of the nasal mucosa makes possible that a 
much reduced dose of allergen can elicit a full response.13 
In patients allergic to grass pollen undergoing a nasal chal-
lenge with orchard (D. glomerata) before the pollen season, 
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Figure 1 cell count, as percentage of the total white cells (mean ± standard deviation).
Figure 2 nasal cytology shows eosinophils (e) with abundant degranulation (D), 
lymphocytes (l), and epithelial cells (c), stained by the May-grunwald-giemsa 
method with a magnification of ×1,000.
Table 2 comorbidities in group a and group B
Comorbidity Group A  
(ragweed and  
grass pollen), n (%)
Group B  
(only ragweed), 
n (%)
sinusitis 1 (4.2) 1 (4.3)
Polyposis 0 0
adenoid hypertrophy 1 (4.2) 3 (13)
Turbinate hypertrophy 0 1 (4.3)
Persistent cough 0 1 (4.3)
Dermatitis 1 (4.2) 1 (4.3)
asa sensitivity 0 0
Drug allergy 1 (4.2) 0
Food allergy 0 0
Abbreviation: asa, acetylsalicylic acid.
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Bousquet et al showed that subjects polysensitized also to 
other pollens, such as cypress, olive, and Parietaria, had 
symptoms occurring earlier than subjects monosensitized 
to grass pollen, this confirming the priming effect.14 Of 
interest, in the same years, it was reported that a priming 
effect was apparently absent in ragweed-allergic patients, as 
showed by similar symptom scores in early and late seasonal 
periods of ragweed pollination, but the patients were allergic 
only to ragweed.15 In this study, we compared the degree of 
inflammation, as evaluated by nasal cytology, in two groups 
of children monosensitized to ragweed pollen or sensitized 
to grass pollen and ragweed pollen, that have different 
pollination periods, with no other sensitization to inhalant 
allergens. Nasal cytology is a useful tool to evaluate AR, 
and a study demonstrated that the ARIA classification of 
AR severity is associated with different patterns of inflam-
matory cells, because patients with moderate-to-severe AR 
have an increased number of mast cells/lymphocytes, while 
the intermittent or persistent nature of the disease does 
not influence the cytological pattern.16 We chose to limit 
the study to children to avoid influence on nasal inflam-
mation by factors other than allergy, particularly cigarette 
smoking. Concerning the main objective of the study, we 
found an abundant presence of inflammatory cells, but no 
significant difference was detected in their number, includ-
ing neutrophils, eosinophils, mast cells, and lymphocytes/
plasma cells, comparing children allergic only to ragweed 
and allergic to grass pollen and ragweed. The high cell 
counts in both groups of children may have made it difficult 
to achieve a statistical significance, but still show that rag-
weed allergy alone elicits a grade of inflammation similar 
to double allergy to ragweed and grass pollen. These find-
ings do not disprove the existence of the priming effect in 
ragweed allergy, but they may suggest that it is not as robust 
as previously found for other pollens. On the other hand, 
ragweed pollen contains nicotinamide adenine dinucleotide 
phosphate (NADPH) oxidase that induces reactive oxygen 
species in mucosal cells independent of adaptive immunity, 
facilitating antigen-induced allergic inflammation.17 In the 
biology of plants, intrinsic pollen NADPH oxidases are 
required to generate reactive oxygen species and induce 
pollen-tube growth.18 In addition, the climatic changes asso-
ciated with the so-called global warming may cooperate, 
having being reported that ragweed plants grown in CO
2
-
enriched environments  produced more allergenic pollens.19 
Such  factors are likely to result in a higher inflammation 
induced by ragweed pollen, as confirmed by our data. 
Conclusion 
The findings from this study suggest that the nasal inflamma-
tion in children with ragweed-induced AR is not influenced 
by additional allergy to grass pollen. This confirm the previ-
ously reported absence of priming effect in ragweed allergy. 
Therefore, ragweed pollen is able to elicit by itself a strong 
inflammatory response in allergic patients. This suggests to 
manage this allergy by treatments not limited to symptomatic 
action but instead addressing the cause of inflammation, such 
as allergen-specific immunotherapy.
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